In patients with high anxiety levels ( HAM-A total score 20 ) , reductions in MADRS total score were -15.20 ( P = 0.122 ) and -15.92 ( P < 0.05 ) for quetiapine XR 150 and 300 mg/day , respectively , vs. placebo ( -13.49 ) .